MindMed Adds Chief Development Officer with FDA Phase 2 Psilocybin Clinical Trial Experience
The Pharma Data
JANUARY 13, 2021
View original content to download multimedia: [link]. MindMed does not undertake any obligation to update publicly any forward-looking statement. Media Contact: mindmed@150bond.com. . . SOURCE Mind Medicine (MindMed) Inc. .
Let's personalize your content